Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.75
0.6014.46%
At close: -
$4.75
0.000.00%
After Hours: Jun 6, 4:00 PM EDT
Comments
Loading...
Contineum Therapeutics Stock Price, Quotes and Forecasts
CTNMNASDAQ
Contineum Therapeutics (CTNM) Forecast
NewsEarningsContineum Therapeutics (CTNM) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Contineum Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CTNM | Benzinga
Explore Contineum Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CTNM.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Contineum Therapeutics (CTNM) stock?
You can purchase shares of Contineum Therapeutics (NASDAQ:CTNM) through any online brokerage.
Who are Contineum Therapeutics (CTNM) competitors?
Other companies in Contineum Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Bioage Labs (NASDAQ:BIOA), Universe Pharmaceuticals (NASDAQ:UPC), Neumora Therapeutics (NASDAQ:NMRA) and Nutriband (NASDAQ:NTRB).
What is the forecast, or price target, for Contineum Therapeutics (CTNM) stock?
Contineum Therapeutics has a consensus price target of $23.80.
What is the current price for Contineum Therapeutics (CTNM)?
The stock price for Contineum Therapeutics (NASDAQ: CTNM) is $4.75 last updated June 6, 2025 at 4:00 PM EDT.
Does Contineum Therapeutics (CTNM) pay a dividend?
There are no upcoming dividends for Contineum Therapeutics.
When is Contineum Therapeutics (NASDAQ:CTNM) reporting earnings?
Contineum Therapeutics’s Q2 earnings are confirmed for Tuesday, August 12, 2025.
Is Contineum Therapeutics (CTNM) going to split?
There is no upcoming split for Contineum Therapeutics.
What sector and industry does Contineum Therapeutics (CTNM) operate in?
Contineum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
